The global Infection Control Market is entering a significant phase of growth as healthcare organizations, pharmaceutical companies, and public health agencies place greater emphasis on minimizing the spread of infectious diseases. Valued at USD 234.91 billion in 2023, the market is projected to climb steadily to USD 417.94 billion by 2032, advancing at a compound annual growth rate...